Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2023 | Reducing inequalities in the diagnosis and treatment of hematological malignancies

Mark Bishton • 24 Apr 2023
BSH 2023
General

In this video, Mark Bishton, MBChB, MRCP, FRCPath, PhD, Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK, briefly discusses the importance of reducing inequalities in the diagnosis and treatment of patients with hematological malignancies, highlighting the value of the National Cancer Registration Service in the UK. This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Roche – conference travel, ad board
Takeda – educational meeting
Lilly – ad board
Celltrion – educational meetings
Incyte – ad board

More from Mark Bishton

Clinical efficacy and safety of CT-P10 in patients with DLBCL
0:44
Clinical efficacy and safety of CT-P10 in patients with DLBCL
Mark Bishton • 24 Apr 2023

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals